Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.38 -1.07 (-3.02%)
Official Closing Price Updated: 7:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,853,690
Open 35.83
Bid (Size) 34.14 (200)
Ask (Size) 34.30 (400)
Prev. Close 35.45
Today's Range 33.18 - 36.46
52wk Range 13.74 - 70.43
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗
One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk. 
Via The Motley Fool
News headline image
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗
Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near. 
Via MarketBeat

Performance

YTD
+2.9%
+2.9%
1 Month
+23.8%
+23.8%
3 Month
+76.9%
+76.9%
6 Month
+8.5%
+8.5%
1 Year
-31.6%
-31.6%

More News

Read More
News headline image
Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗
Via Benzinga
News headline image
Hims & Hers Stock Surges as Analysts Lift Price Targets ↗
Via Benzinga
News headline image
Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 We Question
Via StockStory
News headline image
1 Surging Stock Worth Your Attention and 2 We Find Risky
Via StockStory
Topics Supply Chain
News headline image
Hims & Hers Stock Jumps After Barclays Raises Price Target ↗
Via Benzinga
News headline image
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know ↗
Via Benzinga
News headline image
3 Market-Beating Stocks with Exciting Potential
Via StockStory
News headline image
Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗
Via The Motley Fool
News headline image
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
From Hims & Hers
Via Business Wire
News headline image
1 Growth Stock Set to Flourishand 2 We Ignore
Via StockStory
Topics Economy
News headline image
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
From Hims & Hers
Via Business Wire
News headline image
2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds
Via StockStory
News headline image
Is Hims & Hers Stock an Undervalued Stock to Buy? ↗
Via The Motley Fool
News headline image
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗
Via Benzinga
News headline image
The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗
Via MarketBeat
Topics Earnings
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
Via FinancialNewsMedia
Topics Government
News headline image
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
From Hims & Hers
Via Business Wire
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Hims & Hers Massive Stock Drop Explained ↗
Via The Motley Fool
News headline image
Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering ↗
Via Benzinga

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 34.38
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 07/10/26 07:00 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 6.60B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.